These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7605339

  • 1. Potentiation of chlorambucil toxicity in B-CLL lymphocytes using the DNA synthesis inhibitors aphidicolin and 1-beta-D-arabinofuranosylcytosine.
    Bramson J, Panasci L.
    Biochem Pharmacol; 1995 Jun 29; 50(1):131-5. PubMed ID: 7605339
    [Abstract] [Full Text] [Related]

  • 2. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
    Bramson J, McQuillan A, Aubin R, Alaoui-Jamali M, Batist G, Christodoulopoulos G, Panasci LC.
    Mutat Res; 1995 May 29; 336(3):269-78. PubMed ID: 7739615
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin.
    Christodoulopoulos G, Muller C, Salles B, Kazmi R, Panasci L.
    Cancer Res; 1998 May 01; 58(9):1789-92. PubMed ID: 9581813
    [Abstract] [Full Text] [Related]

  • 4. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin.
    Fram RJ, Kufe DW.
    Cancer Res; 1982 Oct 01; 42(10):4050-3. PubMed ID: 6809309
    [Abstract] [Full Text] [Related]

  • 5. DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards.
    Muller C, Christodoulopoulos G, Salles B, Panasci L.
    Blood; 1998 Oct 01; 92(7):2213-9. PubMed ID: 9746757
    [Abstract] [Full Text] [Related]

  • 6. Imatinib sensitizes CLL lymphocytes to chlorambucil.
    Aloyz R, Grzywacz K, Xu ZY, Loignon M, Alaoui-Jamali MA, Panasci L.
    Leukemia; 2004 Mar 01; 18(3):409-14. PubMed ID: 14712290
    [Abstract] [Full Text] [Related]

  • 7. Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogs.
    Starczewska E, Beyaert M, Michaux L, Vekemans MC, Saussoy P, Bol V, Arana Echarri A, Smal C, Van Den Neste E, Bontemps F.
    Oncotarget; 2016 Jun 21; 7(25):38367-38379. PubMed ID: 27223263
    [Abstract] [Full Text] [Related]

  • 8. The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells.
    de Vries JF, Falkenburg JH, Willemze R, Barge RM.
    Haematologica; 2006 Jul 21; 91(7):912-9. PubMed ID: 16818278
    [Abstract] [Full Text] [Related]

  • 9. Circumvention of ara-C resistance by aphidicolin in blast cells from patients with AML.
    Sargent JM, Elgie AW, Williamson CJ, Lewandowicz GM, Taylor CG.
    Br J Cancer; 2001 Mar 02; 84(5):680-5. PubMed ID: 11237390
    [Abstract] [Full Text] [Related]

  • 10. Effect of DNA polymerase inhibitors on repair of gamma ray-induced DNA damage in proliferating (intact versus permeable) human fibroblasts: evidence for differences in the modes of action of aphidicolin and 1-beta-D-arabinofuranosylcytosine.
    Mirzayans R, Enns L, Cubitt S, Karimian K, Radatus B, Paterson MC.
    Biochim Biophys Acta; 1994 Oct 21; 1227(1-2):92-100. PubMed ID: 7918688
    [Abstract] [Full Text] [Related]

  • 11. Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
    Ganeshaguru K, Wickremasinghe RG, Jones DT, Gordon M, Hart SM, Virchis AE, Prentice HG, Hoffbrand AV, Man A, Champain K, Csermak K, Mehta AB.
    Haematologica; 2002 Feb 21; 87(2):167-76. PubMed ID: 11836167
    [Abstract] [Full Text] [Related]

  • 12. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.
    Christodoulopoulos G, Malapetsa A, Schipper H, Golub E, Radding C, Panasci LC.
    Clin Cancer Res; 1999 Aug 21; 5(8):2178-84. PubMed ID: 10473103
    [Abstract] [Full Text] [Related]

  • 13. Potentiation of ara-C induced cytotoxicity by hydroxyurea in LoVo colon carcinoma cells.
    Robichaud NJ, Fram RJ.
    Biochem Pharmacol; 1987 May 15; 36(10):1673-7. PubMed ID: 3109427
    [Abstract] [Full Text] [Related]

  • 14. The sensitivity of chronic lymphocytic leukaemia lymphocytes to irradiation in vitro.
    Bentley P, Salter R, Blackmore J, Whittaker JA, Hanson JA, Champion AR.
    Leuk Res; 1995 Dec 15; 19(12):985-8. PubMed ID: 8632669
    [Abstract] [Full Text] [Related]

  • 15. Aphidicolin decreases ex vivo resistance to cytosine arabinoside in childhood acute leukaemia.
    Sargent JM, Williamson CJ, Hubeek I, Elgie AW, Taylor CG, Den Boer ML, Peters GJ, Kaspers GL.
    Oncol Rep; 2003 Dec 15; 10(6):2027-31. PubMed ID: 14534738
    [Abstract] [Full Text] [Related]

  • 16. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK, Grever MR, Beer M, Lucas MA, Byrd JC.
    Semin Oncol; 2000 Apr 15; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [Abstract] [Full Text] [Related]

  • 17. Augmentation by aphidicolin of 1-beta-D-arabinofuranosylcytosine-induced c-jun and NF-kappa B activation in a human myeloid leukemia cell line: correlation with apoptosis.
    Kuwakado K, Kubota M, Bessho R, Kataoka A, Usami I, Lin YW, Okuda A, Wakazono Y.
    Leuk Res; 1995 Sep 15; 19(9):645-50. PubMed ID: 7564475
    [Abstract] [Full Text] [Related]

  • 18. Genetic evidence that aphidicolin inhibits in vivo DNA synthesis in Chinese hamster ovary cells.
    Singleton RW, Mishra NC.
    Mol Gen Genet; 1995 May 20; 247(4):462-70. PubMed ID: 7770054
    [Abstract] [Full Text] [Related]

  • 19. Induction of DNA ligase I by 1-beta-D-arabinosylcytosine and aphidicolin in MiaPaCa human pancreatic cancer cells.
    Sun D, Urrabaz R, Buzello C, Nguyen M.
    Exp Cell Res; 2002 Oct 15; 280(1):90-6. PubMed ID: 12372342
    [Abstract] [Full Text] [Related]

  • 20. Chlorambucil plus theophylline vs chlorambucil alone as a front line therapy for B-cell chronic lymphatic leukemia.
    Mabed M, Aref S, Fouda M, El-Sharawy S.
    Leuk Lymphoma; 2004 Oct 15; 45(10):2029-35. PubMed ID: 15370247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.